breast cancer and semaglutide Popular Weight-Loss Drugs Like Ozempic Linked to Lower Risk Breaking down findings of new

The Glucagon Paradox For decades, Glucagon was viewed as the "enemy" of diabetics because it raises blood sugar

Metabolites 11:113 McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet

1 Hemodynamic changes following sodium-glucose cotransporter 2 (SGLT2) inhibition in the kidney

Recent clinical observations suggest that GLP-1 medications like semaglutide may help reduce disease severity by lowering body weight and modulating inflammatory markers associated with HS flare-ups